DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Norflex (Orphenadrine Citrate) - Published Studies

 
 



Norflex Related Published Studies

Well-designed clinical trials related to Norflex (Orphenadrine)

Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial. [2010.11]

Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial. [2010.10.08]

Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial. [2010]

[Diclofenac/orphenadrine as a combined analgetic in post-operative relief of pain] [2008.09.28]

Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery. [2006.09]

Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin. [2005]

Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers. [2004]

Therapeutic response of benzodiazepine, orphenadrine citrate and occlusal splint association in TMD pain. [2003.04]

Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study. [1993.06]

5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. [1990.12]

Well-designed clinical trials possibly related to Norflex (Orphenadrine)

[Diclofenac 75mg. and 30 mg. orfenadine (Neodolpasse) versus placebo and piroxicam in postoperative analgesia after arthroscopy] [2004]

Antiemetic efficacy of granisetron in patients with gynecological malignancies. [1997.03]

Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses. [1994.12]

Effect of central muscle relaxants on single-dose pharmacokinetics of peroral paracetamol in man. [1990.01]

Other research related to Norflex (Orphenadrine)

Orphenadrine induces secondarily generalized convulsive status epilepticus in rats. [2011.04.05]

Full recovery from a potentially lethal dose of orphenadrine ingestion using conservative treatment: a case report. [2010.11]

Determination of orphenadrine plasma levels using HPLC with diode array detection and a novel solid-phase extraction procedure in psychiatric patients. [2009.10.15]

The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine. [2009.08]

Influence of orphenadrine upon the protective activity of various antiepileptics in the maximal electroshock-induced convulsions in mice. [2009.07]

Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine. [2009.04]

Pharmacokinetic, metabolism and withdrawal time of orphenadrine in camels (Camelus dromedarius) after intravenous administration. [2008.12]

Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine. [2006.05]

Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine. [2003.06]

Upregulation of cytochromes P450 2B in rat liver by orphenadrine. [2003.06]

Acute intoxication with orphenadrine and clozapine. [2001.11.15]

Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. [2001.02]

Central anticholinergic syndrome from orphenadrine in a 3 year old. [2000.04]

Orphenadrine poisoning in a child: clinical and analytical data. [1999.10]

[Results of efficacy study with diclofenac/orphenadrine infusions in patients with musculoskeletal diseases and functional disorders] [1998]

[Diclofenac/orphenadrine infusion therapy in patients with active arthrosis] [1998]

Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo. [1995.07]

Reversal of orphenadrine-induced ventricular tachycardia with physostigmine. [1991.11]

Clinical and pharmacological review of the efficacy of orphenadrine and its combination with paracetamol in painful conditions. [1991.03]

Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine. [1989.11]

Misleading T3-test values in psychiatric patients treated with orphenadrine. [1987]

Other possibly related research studies

Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient. [2007]

Objective high-frequency tinnitus of middle-ear myoclonus. [2004.03]

[Diagnostic image (17). Acute dystonia induced by prochlorperazine] [2000.12.23]

Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy. [2000.05]

[Atypical acute dystonia] [1998.12.14]

[Fatalities caused by anticholinergic antiparkinsonian drugs. Analysis of findings in a 11-year national material] [1998.01.10]

Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy. [1993.04]

Recurrent neuroleptic malignant syndrome in a man with mild mental handicap. [1992.08]

Excessive use of anticholinergic drugs in a sub-sample of Italian schizophrenics. [1991.05]

Combined levodopa-anticholinergic therapy in the treatment of Parkinson's disease. Effect on levodopa bioavailability. [1991.04]

Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose. [1991.01]

Acetylcholine and choline levels in rabbit fetuses exposed to anticholinergics. [1987]

Are there alternatives to the use of quinine to treat nocturnal leg cramps? [2008.02]

Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU. [2008.01]

Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism. [2009.01]

The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. [2009.02]

Evidence-based intravenous pain treatment with analgesic infusion regimens. [2010]

Conservative interventions provide short-term relief for non-specific neck pain: a systematic review. [2010]

Muscle relaxants for pain management in rheumatoid arthritis. [2012]

Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study. [2014]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017